医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

EverEx Secures iF Design Award for “MORA,” a Leading Musculoskeletal Rehabilitation Solution

2024年03月28日 PM01:17
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

EverEx, a musculoskeletal digital healthcare startup in South Korea, has been honored with the world-renowned design prize, the iF Design Award. The award for “MORA,” in the service design category for healthcare, highlights the company’s significant achievements.

Organized annually by the Hannover-based iF International Forum Design GmbH, the iF Design Award is highly revered in the design community. With its outstanding functionality, user interface, and experience, “MORA” captured the attention of a 132-member jury of international experts, triumphing amidst a competitive field of nearly 11,000 entries from 72 countries. This accolade, following closely after the CES 2024 Innovation Award win in digital healthcare, further cements EverEx’s position as a leader in musculoskeletal rehabilitation.

Dr. Chan Yoon, CEO of EverEx, commented, “Winning the iF Design Award underscores our commitment to enhancing the efficiency and accessibility of rehabilitation practices through digital innovation. We remain dedicated to the continual improvement of our products, valuing the feedback from our users to adapt to the evolving demands of digital healthcare environments.”

“MORA” product lines provide EverEx’s proprietary AI pose estimation model-powered musculoskeletal assessment and personalized rehabilitation treatment with remote therapeutic monitoring.

Recently, the digital therapeutics (DTx) product ‘MORA Cure’ has completed the Investigational Device Exemption (IDE) process and got approval from the South Korean Ministry of Food and Drug Safety (MFDS) as the first DTx in the musculoskeletal field to proceed with a clinical trial specifically targeting patellofemoral pain syndrome. This achievement underscores EverEx’s commitment to advancing solutions for musculoskeletal disorders and represents a significant step forward in its efforts to introduce effective digital therapies to the market.

Moreover, EverEx has introduced AI-powered FDA Class 2 software medical device “EverEx Rehab” to the U.S. market, targeting musculoskeletal remote therapeutic monitoring (RTM). Its well-received presentation at the American Physical Therapy Association conference has sparked significant interest among healthcare professionals.

About EverEx

Founded in August 2019 by orthopedic surgeon Dr. Chan Yoon, EverEx is a global digital healthcare startup focusing on musculoskeletal health. Driven by the goal to enhance digital rehabilitation solutions for musculoskeletal conditions, EverEx has assembled a multidisciplinary team of approximately 40 experts in orthopedics, rehabilitation medicine, psychiatry, and various technology fields. Coming off a recent win at the CES 2024 Innovation Award, EverEx is poised for significant expansion in the U.S. market with EverEx Rehab. For more information, visit everex.health.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240326352594/en/

CONTACT

EverEx

hello@everex.ai

同じカテゴリーの記事 

  • NADクリニックとボンタック・バイオエンジニアリング(深セン)が戦略的提携、NAD+の力で世界によりよいウェルネスの未来を
  • NADclinic和Bontac Bio-Engineering (Shenzhen) Co., Ltd宣布建立战略合作伙伴关系,通过NAD+的力量开拓全球健康的未来
  • Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast
  • Brenmiller’s Project Pipeline Expands to 49 Projects Representing Over $500 Million in Potential Value in 12 Industries Across 13 Countries
  • NADclinic and Bontac Bio-Engineering (Shenzhen) Co., Ltd Announce Strategic Partnership to Evolve the Future of Global Wellness Through the Power of NAD+